Brigitte Kieffer

Definition
Brigitte Kieffer is a French neuroscientist renowned for her research on the molecular mechanisms of addiction, pain, and emotional behavior, particularly involving opioid receptors.

Overview
Born on 13 February 1958 in Paris, France, Kieffer earned her doctorate in biomedical science from the University of Paris – Des Cartes. She served as a professor at the Collège de France, holding the Chair of Neurobiology of the Mood and Addictive Disorders from 2006 to 2018. Throughout her career, Kieffer has directed several research institutions, including the Institut de Neurosciences de la Timone (Paris) and the Institute of Pharmacology and Structural Biology (IPSB) at the French National Institute of Health and Medical Research (INSERM).

Kieffer’s most influential work centers on the discovery and functional characterization of the μ‑opioid receptor (MOR) gene knockout mouse, a model that has facilitated the study of opioid signaling in pain, reward, and stress. Her investigations have contributed to a deeper understanding of the genetic and neurobiological bases of addiction and mood disorders, influencing therapeutic strategies for opioid use disorder and depression.

She has authored more than 200 peer‑reviewed publications, received numerous honors—including the Grand Prix de la Recherche from the French Academy of Sciences (2004), the L'Oréal‑UNESCO Award for Women in Science (2002), and election to the French Academy of Sciences (2010)—and serves on several international scientific advisory boards.

Etymology/Origin
The name “Brigitte” is of Celtic origin, derived from “Brigid,” meaning “strength” or “exalted one.” “Kieffer” is a Germanic surname, historically associated with the occupational term for a cooper or barrel maker. In the French context, the surname is present among families of Alsatian or German descent.

Characteristics

• Research Focus: Opioid receptor biology, neurogenetics of addiction, pain modulation, emotional regulation, and neuropsychiatric disorders.
• Methodological Approach: Utilization of genetic knockout models, molecular biology, electrophysiology, behavioral assays, and translational pharmacology.
• Professional Roles: University professor, research institute director, member of the Collège de France, and scientific committee member of European research agencies.
• Key Contributions:
  1. Generation of the first µ‑opioid receptor‑deficient mouse, elucidating the receptor’s role in analgesia and reward.
  2. Identification of gene networks linking opioid signaling to stress and depressive phenotypes.
  3. Advocacy for gender equality in science and mentorship of early‑career researchers.

Related Topics

• Opioid receptors (µ, δ, κ) and endogenous opioid peptides.
• Addiction neuroscience and substance‑use disorder research.
• Pain physiology and analgesic drug development.
• Neurobiology of mood disorders.
• French scientific institutions (INSERM, Collège de France).
• Women in STEM and scientific leadership.